+49.3%
GSK vs MTB
+118.5%
-69.3%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | MTB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | -0.6% | -2.1% | -2.7% |
| 7D | -4.2% | +2.8% | -7.0% | -4.4% |
| 30D | -7.5% | -4.2% | -3.3% | -7.2% |
| 3M | -3.3% | +7.8% | -11.1% | -4.0% |
| 6M | -9.3% | +14.8% | -24.1% | -10.4% |
| YTD | +1.6% | +20.8% | -19.2% | +0.2% |
| 1Y | +25.5% | +23.1% | +2.4% | +23.7% |
| 3Y | +49.3% | +114.8% | -65.6% | +37.8% |
| All | +49.3% | +118.5% | -69.3% | +37.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MTB.
Daily Out/Under-Performance
Portfolio return minus MTB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MTB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded MTB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling